OGN | | Organon & Co. | WALSH MATTHEW M | Chief Financial Officer | Mar 31, 2024 | Option Exercise | $18.80 | 9,752 | 183,338 | 84,109 | Apr 03, 2024, 06:42 PM |
OGN | | Organon & Co. | WALSH MATTHEW M | Chief Financial Officer | Feb 28, 2024 | Option Exercise | $18.04 | 11,393 | 205,530 | 74,062 | Mar 01, 2024, 04:24 PM |
OGN | | Organon & Co. | WALSH MATTHEW M | Chief Financial Officer | Aug 05, 2023 | Option Exercise | $21.53 | 11,006 | 236,959 | 52,411 | Aug 08, 2023, 06:07 PM |
OGN | | Organon & Co. | WALSH MATTHEW M | Chief Financial Officer | May 04, 2023 | Option Exercise | $24.24 | 4,043 | 98,002 | 41,070 | May 08, 2023, 06:46 PM |
OGN | | Organon & Co. | WALSH MATTHEW M | Chief Financial Officer | Mar 31, 2023 | Option Exercise | $23.09 | 2,656 | 61,327 | 36,803 | Apr 04, 2023, 08:21 PM |
CERT | | Certara, Inc. | WALSH MATTHEW M | Director | Nov 14, 2022 | Sale | $14.74 | 12,059 | 177,750 | 167,901 | Nov 15, 2022, 04:50 PM |
OGN | | Organon & Co. | WALSH MATTHEW M | Chief Financial Officer | Aug 05, 2022 | Option Exercise | $32.41 | 10,790 | 349,704 | 31,706 | Aug 09, 2022, 07:52 PM |
OGN | | Organon & Co. | WALSH MATTHEW M | Chief Financial Officer | May 04, 2022 | Option Exercise | $32.44 | 2,847 | 92,357 | 20,153 | May 05, 2022, 08:53 PM |
OGN | | Organon & Co. | WALSH MATTHEW M | Chief Financial Officer | Aug 05, 2021 | Option Exercise | $28.63 | 29,996 | 858,785 | 22,343 | Aug 09, 2021, 04:44 PM |
CERT | | Certara, Inc. | WALSH MATTHEW M | Director | Dec 15, 2020 | Buy | $23.00 | 5,000 | 115,000 | 172,901 | Dec 16, 2020, 06:58 PM |
AGN | | Allergan plc | WALSH MATTHEW M | EVP, Chief Financial Officer | Mar 02, 2020 | Option Exercise | $193.84 | 15,476 | 2,999,868 | 39,657 | Mar 04, 2020, 02:17 PM |
AGN | | Allergan plc | WALSH MATTHEW M | EVP, Chief Financial Officer | Feb 20, 2019 | Option Exercise | $140.33 | 2,235 | 313,638 | 24,181 | Feb 21, 2019, 05:41 PM |
AGN | | Allergan plc | WALSH MATTHEW M | EVP, Chief Financial Officer | Nov 16, 2018 | Buy | $157.00 | 1,000 | 157,000 | 26,416 | Nov 19, 2018, 07:22 PM |
AGN | | Allergan plc | WALSH MATTHEW M | EVP, Chief Financial Officer | Mar 08, 2018 | Buy | $153.96 | 1,000 | 153,960 | 25,416 | Mar 08, 2018, 10:44 AM |
AGN | | Allergan plc | WALSH MATTHEW M | EVP, Chief Financial Officer | Feb 20, 2018 | Option Exercise | $160.59 | 22,416 | 3,599,785 | 22,416 | Feb 22, 2018, 04:25 PM |
AGN | | Allergan plc | WALSH MATTHEW M | EVP, Chief Financial Officer | Feb 21, 2018 | Buy | $160.94 | 2,000 | 321,880 | 24,416 | Feb 22, 2018, 04:25 PM |
CTLT | | Catalent, Inc. | WALSH MATTHEW M | EVP & Chief Financial Officer | Aug 24, 2017 | Option Exercise | $35.21 | 8,245 | 290,306 | 103,703 | Aug 28, 2017, 12:29 PM |
CTLT | | Catalent, Inc. | WALSH MATTHEW M | EVP & Chief Financial Officer | Jul 31, 2017 | Option Exercise | $34.97 | 3,230 | 112,953 | 95,757 | Aug 01, 2017, 06:35 PM |
CTLT | | Catalent, Inc. | WALSH MATTHEW M | See Remarks | Jun 08, 2017 | Option Exercise | $21.55 | 121,554 | 2,619,879 | 168,363 | Jun 12, 2017, 04:36 PM |
CTLT | | Catalent, Inc. | WALSH MATTHEW M | See Remarks | May 27, 2016 | Option Exercise | $22.27 | 178,248 | 3,969,237 | 140,688 | Jun 01, 2016, 05:35 PM |
CTLT | | Catalent, Inc. | WALSH MATTHEW M | See Remarks | Jul 27, 2015 | Option Exercise | $21.11 | 169,434 | 3,576,575 | 130,880 | Jul 29, 2015, 01:58 PM |
CTLT | | Catalent, Inc. | WALSH MATTHEW M | See Remarks | Apr 06, 2015 | Sale | $20.59 | 204,469 | 4,209,704 | 184,546 | Apr 08, 2015, 11:08 AM |
CTLT | | Catalent, Inc. | WALSH MATTHEW M | See Remarks | Mar 27, 2015 | Option Exercise | $30.10 | 11,039 | 332,274 | 84,503 | Mar 31, 2015, 06:23 PM |
CTLT | | Catalent, Inc. | WALSH MATTHEW M | See Remarks | Feb 13, 2015 | Sale | $28.11 | 3,200 | 89,952 | 95,542 | Feb 18, 2015, 06:50 PM |